-
COVID Rates Have Plateaued, May Rise. Don’t Relax Your Protections!
Key Points: In today’s Recommendations for Industry, we discuss the flattened rate of COVID transmission increasing the urgency to maintain all protections and TAG’s US Risk Matrix. There is potential that cases may be rising. Read More Here. With a new vaccine on the market (Johnson & Johnson), the New York Times breaks down what…
-
J&J Vaccine Authorized & Rolling Out
Key Points: In today’s Recommendations for Industry, we discuss FDA’s issuance of an EUA for the J&J Janssen COVID-19 Vaccine for those 18 years of age and older. Read more below. The Johnson and Johnson’s EUA has been approved by the FDA and recommended by the CDC. Last week, we discussed the J&J vaccine. Check…
-
J&J Vaccine Review (and authorization?) Coming Today
J&J Vaccine Review (and authorization?) Coming Today Key Points: In today’s Recommendations for Industry, we discuss the J&J vaccine being reviewed for EUA by FDA today. [Read More below] The FDA is allowing for more flexible storage and transportation conditions for the Pfizer COVID-19 vaccine; undiluted frozen vials of the vaccine can be “transported and…
-
Post-Vaccine Symptomatic Return to Work
Key Points: In today’s Recommendations for Industry, we discuss post-vaccine symptomatic return to work for those receiving the vaccine and not feeling well. In addition, we discuss the US Risk Matrix. [Read More] Johnson and Johnson’s EUA documentation submitted to the FDA has been released. We will discuss this more on Friday. In the huge…
-
COVID-19 Vaccine Progress and Education
Key Points: In today’s Recommendations for Industry, we discuss the current status of vaccinations across the U.S. and the importance of education. Read more below. The New York Times discusses vaccine alarmism that addresses the conflicting messages that “may be dissuading people from getting vaccinated.” According to NYT polls, “nearly half of Americans would refuse…
-
Why Office Mask Wearing Is Still Essential
Key Points: In today’s Recommendations for Industry, we discuss the continued need for mask wearing in offices. Read More. FDA and HHS have reiterated that there is no current epidemiologic and scientific information of food or food packaging as associated with or being a likely source of viral transmission of severe acute respiratory syndrome coronavirus…
-
TAG’s COVID-19 Risk Matrix Confirms Downward Trend
Key Points: In today’s Recommendations for Industry, we discuss the TAG COVID-19 Risk Matrix showing that cases and case rates are dropping in the U.S. and globally. The CDC is hosting the National Forum on COVID-19 Vaccine from February 22 – 24, 2021. Find out more and register at the CDC’s website. Cases of Multisystem…
-
COVID-19 Variants Raise Questions
Key Points: In today’s Recommendations for Industry, we discuss COVID-19 variants Identified around the world continuing to raise questions, those studied appear to be variations in the spike protein. Read More below. When referring to individuals who are “fully vaccinated”, this refers to individuals that have waited at least two weeks post receiving (a) the…
-
Layered Masks & COVID-19 Vaccination Update
Key Points: In today’s Recommendations for Industry, we discuss new recommendations from CDC for masks and quarantining vaccinated persons. Read more below. The CDC has declared that individuals who have received the full course of a COVID-19 vaccine do not need to quarantine for 10 – 14 days post-exposure to a COVID-infected individual, as long…
-
U.S. Continues Downward COVID-19 Trend – But Awaits Potential Variant Impacts
Key Points: In today’s Recommendations for Industry, we discuss the TAG Risk Matrix and potential variant impact on the current downward trend of the virus. Read more here. Recently the WHO arrived in China to understand the source of the SARS-CoV-2 virus. You can watch the WHO Video briefing (Twitter). It is “extremely unlikely” that…